Pimstone Simon N. 的 Form 4/A 修正申報
修正Xenon Pharmaceuticals Inc.XENE,2022/3/8 申報
- 申報編號
- 0001209191-22-017418
- 申報時間
- 2022/3/8
- 交易日
- 2022/3/8
- 申報延遲
- 當天
- 10b5-1 計畫
- 表單沒有這欄(2023 年以前)
- 原始申報日
- 2022/3/8
這份申報列了 1 筆非衍生性交易。沿用原件裡沒有重述的 20 筆交易。公開市場賣出合計 $167.7 萬。交易當天就申報。
這份修正申報重述了 0001209191-22-017341(2022/3/8 申報)的一部分,沒有重述的交易仍然有效,列在下面。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Pimstone Simon N.CIK 0001620084 | 董事 |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/3/8 | Common Shares | S賣出處分 | −2,500 | $30.80F1 | −$77,000 | 193,135 | 直接 |
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。
來自 0001209191-22-017341(2022/3/8 申報)。
非衍生性證券(表 I)
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/3/4 | Common Shares | M行使選擇權取得 | +10,288 | $3.67F1 | +$37,756.96 | 220,474 | 直接 | |
| 2022/3/4 | Common Shares | F扣股繳稅處分 | −963 | $31.42F2 | −$30,257.46 | 219,511 | 直接 | |
| 2022/3/4 | Common Shares | S賣出處分 | −4,532 | $30.66F3 | −$138,951.12 | 214,979 | 直接 | |
| 2022/3/4 | Common Shares | S賣出處分 | −4,793 | $30.56F4 | −$146,474.08 | 210,186 | 直接 | |
| 2022/3/7 | Common Shares | M行使選擇權取得 | +20,576 | $3.67F1 | +$75,513.92 | 230,762 | 直接 | |
| 2022/3/7 | Common Shares | F扣股繳稅處分 | −1,990 | $30.23F5 | −$60,157.7 | 228,772 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −5,037 | $30.60F6 | −$154,132.2 | 223,735 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −4,517 | $30.49F7 | −$137,723.33 | 219,218 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −4,516 | $30.45F8 | −$137,512.2 | 214,702 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −4,516 | $30.44F9 | −$137,467.04 | 210,186 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −2,500 | $30.52 | −$76,300 | 207,686 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −7,500 | $30.50 | −$228,750 | 200,186 | 直接 | |
| 2022/3/7 | Common Shares | S賣出處分 | −2,500 | $30.55 | −$76,375 | 197,686 | 直接 | |
| 2022/3/8 | Common Shares | S賣出處分 | −2,051 | $30.60 | −$62,760.6 | 195,635 | 直接 | |
| 2022/3/8 | Common Shares | S賣出處分 | −2,500 | $30.10 | −$75,250 | 190,635 | 直接 | |
| 2022/3/8 | Common Shares | S賣出處分 | −2,500 | $30.20 | −$75,500 | 188,135 | 直接 | |
| 2022/3/8 | Common Shares | S賣出處分 | −2,500 | $30.55F11 | −$76,375 | 185,635 | 直接 | |
| 2022/3/8 | Common Shares | S賣出處分 | −2,500 | $30.50 | −$76,250 | 183,135 | 直接 |
衍生性證券(表 II)
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/3/4 | Common Shares | M行使選擇權處分 | −10,288 | $0.00 | $0 | 0 | 直接 | |
| 2022/3/7 | Common Shares | M行使選擇權處分 | −20,576 | $0.00 | $0 | 0 | 直接 |
原件的附註
這幾筆交易的價格在原件上引用的附註。
- F1
The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.
表 I 有 2 筆交易的價格引用這則附註。
- F2
Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.49 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.53 to $30.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the closing price of the Company's common shares on March 4, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.4865 to $30.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.480 to $30.645, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.4100 to $30.4750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.40 to $30.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F11
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.55 to $30.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
表 I 有 1 筆交易的價格引用這則附註。
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.800 to $30.880, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
備註
This amendment corrects the share price that was inaccurately reported on the original Form 4 due to a clerical error.